Prøve GULL - Gratis
Dr. Reddy's to focus on complex drugs
Mint Bangalore
|January 24, 2025
The pharma major posted its highest ever quarterly results and Ebitda this quarter
Dr. Reddy's is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide), and biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug Revlimid next year, a top executive said.
As gRevlimid, the drug that has been the biggest growth driver for the company in recent years, nears its patent expiry in January 2026, the pharma major has additional growth drivers in place to continue the momentum, Erez Israeli, CEO, Dr. Reddy's, said.
Israeli was speaking at a press briefing post the company's Q3FY25 results.
Denne historien er fra January 24, 2025-utgaven av Mint Bangalore.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Bangalore
Mint Bangalore
Advent exits Aditya Birla Cap, nets 2.5x
US private equity firm Advent International Corp. on Wednesday sold its entire 2% stake in Aditya Birla Capital Ltd (ABCL) via a block deal, raising about ₹1,638-1,640 crore.
1 mins
October 30, 2025
Mint Bangalore
MARKETS LOOK TOPPY, GOLD LOOKS TIRED—HERE'S HOW TO STAY INVESTED SMARTLY
Market chatter has turned cautious, with many experts warning that a correction in equities and gold may be around the corner. Such alerts deserve attention—but not alarm. After all, timing the market is nearly impossible.
3 mins
October 30, 2025
Mint Bangalore
Is PoA valid to sell a property if owner loses mental capacity?
Six months ago, my father gave me a registered power of attorney (PoA) to sell his property. He slipped into a coma last month. Can I still sell it under that PoA? —Name withheld on request
2 mins
October 30, 2025
Mint Bangalore
India, EU to push trade talks on steel, carbon tax issues
India and the European Union (EU) have agreed to continue discussions on issues pertaining to steel, auto, and carbon tax, as these areas carry higher sensitivities, under the proposed free trade agreement, the commerce ministry said on Wednesday.
1 mins
October 30, 2025
Mint Bangalore
Varun Beverages surges 9% on Carlsberg deal despite weak Q2
Shares of PepsiCo bottler Varun Beverages surged over 9% on Wednesday after the company announced an exclusive distribution partnership with Carlsberg Breweries for select southern African markets.
1 mins
October 30, 2025
Mint Bangalore
Follow your nose down the bylanes of history
‘The Secret Power of Scent’ takes visitors on a 1,000-year journey
2 mins
October 30, 2025
Mint Bangalore
'Akasa will look at IPO in next 2-5 yrs'
Akasa Air will look at an initial public offering (IPO) in the next two to five years, its founder and chief executive officer Vinay Dube said on Wednesday and asserted that the airline will not chase “growth for the sake of growth”.
1 min
October 30, 2025
Mint Bangalore
Govt preps debt recast plan for discoms
Drugmakers face bans for fake claims as govt set to tweak rules
2 mins
October 30, 2025
Mint Bangalore
Bougatsa is a Greek breakfast worth waking for
This custard-filled treat, which dates back to the time of the Byzantine Empire, is a delicious slice of Athens life
3 mins
October 30, 2025
Mint Bangalore
Silver premiums fall as demand eases
Silver premiums in India have fallen sharply as demand eased following the last two weeks’ festive rush, prompting potential buyers to delay purchases, bullion dealers told Reuters.
1 min
October 30, 2025
Listen
Translate
Change font size

